P

Pure Biologics SA
WSE:PUR

Watchlist Manager
Pure Biologics SA
WSE:PUR
Watchlist
Price: 3.562 PLN -2.2%
Market Cap: 43.6m PLN

Wall Street
Price Targets

PUR Price Targets Summary
Pure Biologics SA

There are no price targets for PUR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Pure Biologics SA Competitors:
Price Targets
2696
Shanghai Henlius Biotech Inc
78% Upside
DVAX
Dynavax Technologies Corp
38% Upside
CYTK
Cytokinetics Inc
31% Upside
PGEN
Precigen Inc
107% Upside
2171
CARsgen Therapeutics Holdings Ltd
55% Upside
87S
Roivant Sciences Ltd
13% Upside
CRSP
CRISPR Therapeutics AG
53% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
38% Upside

Revenue
Forecast

Revenue Estimate
Pure Biologics SA

Revenue forecast
is not available for
Pure Biologics SA

Operating Income
Forecast

Operating Income Estimate
Pure Biologics SA

Operating Income forecast
is not available for
Pure Biologics SA

Net Income
Forecast

Net Income Estimate
Pure Biologics SA

Net Income forecast
is not available for
Pure Biologics SA
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PUR's stock price target?
Not Available

PUR doesn't have any price targets made by Wall Street professionals.

Back to Top